What we have learned from the Palisade Study, where will it lead future research? Persistent chylomicronemia risk management by triglyceride-level reduction
| Event title | Event dates | Event venue | Website of the event | Main speciality | Name of the CME provider | Amount of ECMEC® credits |
|---|---|---|---|---|---|---|
| What we have learned from the Palisade Study, where will it lead future research? Persistent chylomicronemia risk management by triglyceride-level reduction | 27/10/2026 - 27/10/2026 | Sweden, Gothenburg | Website | Cardiology | European Atherosclerosis Society | 1.0 European CME credits (ECMEC®) |
